Source: International Congress 2018 – Improving the quality of life of patients with bronchiectasis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
J. Chalmers (Dundee, United Kingdom), E. Polverino (Barcelona, Spain), F. Blasi (Milan, Italy), F. Ringshausen (Hannover, Germany), A. De Soyza (Newcastle, United Kingdom), M. Vendrell (Girona, Spain), P. Goeminne (Belgium, Belgium), W. Boersma (Alkmaar, Netherlands), C. Haworth (Cambridge, United Kingdom), M. Murris (Hôpital Larrey-CHU de Toulouse, France), A. Hill (Edinburgh, United Kingdom), M. Loebinger (London, United Kingdom), R. Menendez (Valencia, Spain), A. Torres (Barcelona, Spain), K. Dimakou (Athens, Greece), T. Welte (Hannover, Germany), R. Wilson (London, United Kingdom), S. Elborn (London, United Kingdom), S. Aliberti (Milan, United Kingdom). The heterogeneity of bronchiectasis patient characteristics, management and outcomes across Europe: Data from the EMBARC registry. 2676

Member's Comments

No comment yet.

Related content which might interest you: Demographics, clinical characteristics, health resource utilization and cost of patients with CTEPH: Retrospective results from six European countries Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism Year: 2012 A comparison of the management of COPD exacerbations in six European hospitals: demographics and baseline data Source: Annual Congress 2008 - Management of COPD Year: 2008 Sex related differences in aetiology, severity and quality of life in bronchiectasis: data from the EMBARC, EMBARC-India and Australian bronchiectasis registries Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria Year: 2020 Heterogeneity in bronchiectasis service provision in Europe: Baseline data from the European bronchiectasis registry (EMBARC) Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook Year: 2015 Clinical characteristics, mortality rates and causes of death in non-exacerbating COPD patients. A longitudinal cohort analysis of UK primary care data. Source: Virtual Congress 2021 – New evidence from longitudinal COPD cohorts and other key studies Year: 2021 Evaluation of the demographics, diagnosis and monitoring, management, device usage and adherence among COPD patients: A survey of doctors in Nepal Source: International Congress 2018 – COPD around the world Year: 2018 Demographic, clinical and health care resource utilisation characterisation of patients prescribed omalizumab: A retrospective, real world data study Source: International Congress 2014 – Intervening in allergic asthma Year: 2014 The Spanish national clinical audit on COPD exacerbations. Results of a pilot study: main outcomes Source: Annual Congress 2008 - Prognosis in COPD Year: 2008 AUDIPOC: Spanish national clinical audit on COPD exacerbations. Results from the initial selection of cases Source: Annual Congress 2009 - Epidemiology of COPD and infectious lung diseases Year: 2009 Interims analysis of the EXCITING-ILD registry (registry for exploring clinical and epidemiological characteristics of interstitial lung diseases) Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 COPD therapy based on clinical phenotypes: Baseline data from the Czech multicentre research database of COPD Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 Patient burden of not well-controlled asthma: results of a European survey Source: Annual Congress 2009 - Asthma treatment and control strategies in primary care Year: 2009 Population-based analysis of COPD patients in Catalonia: implications for case management Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies? Year: 2017 Time trends in clinical characteristics of patients with severe asthma: data from the Belgian Severe asthma register (BSAR) Source: International Congress 2018 – Tests and trends in asthma Year: 2018 The prevalence and impact of autoantibodies among people with bronchiectasis: a data analysis of the EMBARC registry Source: Virtual Congress 2021 – Bronchiectasis Year: 2021 Long term clinical outcomes of bronchiectasis in India: Data from the EMBARC/RRNI Indian Bronchiectasis Registry Source: Virtual Congress 2021 – Respiratory infections and bronchiectasis outcomes Year: 2021 Gender differences in long-term outcomes of COPD: A population based study in Italy Source: International Congress 2014 – Longitudinal studies of respiratory disease Year: 2014 Survival estimates in European cystic fibrosis patients and the impact of socioeconomic factors: a retrospective registry cohort study Source: Eur Respir J, 58 (3) 2002288; 10.1183/13993003.02288-2020 Year: 2021 The association between COPD treatment adherence and patient outcomes in Europe and the US Source: International Congress 2016 – Asthma, COPD, and ACOS: physical activity, dietary aspects, and diseases burden Year: 2016 Deteriorating heath status in bronchiectasis : longitudinal data from the EMBARC registry Source: Virtual Congress 2021 – Respiratory infections and bronchiectasis outcomes Year: 2021